Integrated Wealth Concepts’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
IWS
Integrated Wealth Concepts's IHE Position: Q2 2026 in Review
Integrated Wealth Concepts opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 758 shares worth $75.1K. The stake represents ﹤0.01% of the portfolio and ranks #3037 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in IHE as recently as Q4 2024.
Integrated Wealth Concepts first reported a position in IHE in Q3 2021 and has held it in 15 quarters since. The position peaked at $1.07M in Q3 2024. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- Integrated Wealth Concepts held 758 shares of iShares US Pharmaceuticals ETF worth $75.1K as of Q2 2026.
- iShares US Pharmaceuticals ETF was a new Integrated Wealth Concepts position in Q2 2026.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #3037 holding.
- Integrated Wealth Concepts first reported a position in iShares US Pharmaceuticals ETF in Q3 2021 and has held it in 15 quarters since.
- Integrated Wealth Concepts's iShares US Pharmaceuticals ETF position peaked at $1.07M in Q3 2024.
- 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.